Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Lim, KHJ"'
Autor:
Lim, KHJ, Punie, K, Oing, C, Thorne, E, Murali, K, Kamposioras, KV, O'Connor, M, Elez, E, Amaral, TMS, Lopez, PG, Lambertini, M, Devnani, B, Westphalen, CB, Morgan, G, Haanen, JBAG, Hardy, C, Banerjee, S
Publikováno v:
ESMO Congress
S1131
S1130
S1131
S1130
Background The ESMO Resilience Task Force has investigated wellbeing since COVID-19 in relation to work, lifestyle and support factors in oncology professionals globally. We reported on the significant impact of the initial surge of the pandemic on w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::757aba9a1f618943b101a04e8d66a6c9
http://hdl.handle.net/10044/1/92188
http://hdl.handle.net/10044/1/92188
Autor:
Lim, K. H. J., Murali, K., Thorne, E., Punie, K., Kamposioras, K., Oing, C., O'Connor, M., Elez, Elena, Amaral, T., Garrido, Pilar, Lambertini, M., Devnani, B., Westphalen, C. B., Morgan, G., Haanen, J. B. A. G., Hardy, C., Banerjee, Susana, Universidad Autònoma de Barcelona
Publikováno v:
ESMO Open
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientia
Highlights • Risk of distress/burnout amongst oncology professionals continues to worsen since COVID-19 despite improved job performance. • Female and younger (≤40 years old) colleagues continue to be at higher risk of poor well-being and feeli
Autor:
Giampazolias E; Immunobiology Laboratory, The Francis Crick Institute, London NW1 1AT, UK.; Cancer Immunosurveillance Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Pereira da Costa M; Immunobiology Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Lam KC; Inflammatory Cell Dynamics Section, Laboratory of Integrative Cancer Immunology (LICI), Center for Cancer Research (CCR), National Cancer Institute (NCI), Bethesda, MD 20892, USA., Lim KHJ; Immunobiology Laboratory, The Francis Crick Institute, London NW1 1AT, UK.; Department of Immunology and Inflammation, Imperial College London, London SW7 2AZ, UK., Cardoso A; Immunobiology Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Piot C; Immunobiology Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Chakravarty P; Bioinformatics and Biostatistics STP, The Francis Crick Institute, London NW1 1AT, UK., Blasche S; MRC Toxicology Unit, University of Cambridge, Cambridge CB2 1QR, UK., Patel S; Cancer Immunosurveillance Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Biram A; Immunobiology Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Castro-Dopico T; Immunobiology Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Buck MD; Immunobiology Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Rodrigues RR; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.; Microbiome and Genetics Core, LICI, CCR, NCI, Bethesda, MD 20892, USA., Poulsen GJ; National Center of Excellence for Molecular Prediction of Inflammatory Bowel Disease, PREDICT, Faculty of Medicine, Aalborg University, Department of Gastroenterology and Hepatology, Aalborg University Hospital, A DK-2450 Copenhagen, Denmark., Palma-Duran SA; Metabolomics STP, The Francis Crick Institute, London NW1 1AT, UK., Rogers NC; Immunobiology Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Koufaki MA; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Minutti CM; Immunobiology Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Wang P; Cancer Immunosurveillance Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Vdovin A; Cancer Immunosurveillance Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Frederico B; Immunobiology Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Childs E; Immunobiology Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Lee S; Immunobiology Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Simpson B; Tumor Immunogenomics and Immunosurveillance (TIGI) Lab, UCL Cancer Institute, London WC1E 6DD, UK., Iseppon A; AhRimmunity Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Omenetti S; AhRimmunity Laboratory, The Francis Crick Institute, London NW1 1AT, UK., Kelly G; Bioinformatics and Biostatistics STP, The Francis Crick Institute, London NW1 1AT, UK., Goldstone R; Bioinformatics and Biostatistics STP, The Francis Crick Institute, London NW1 1AT, UK., Nye E; Experimental Histopathology, The Francis Crick Institute, London NW1 1AT, UK., Suárez-Bonnet A; Experimental Histopathology, The Francis Crick Institute, London NW1 1AT, UK.; Department of Pathobiology and Population Sciences, The Royal Veterinary College, North Mimms, Hatfield, Hertfordshire AL9 7TA, UK., Priestnall SL; Experimental Histopathology, The Francis Crick Institute, London NW1 1AT, UK.; Department of Pathobiology and Population Sciences, The Royal Veterinary College, North Mimms, Hatfield, Hertfordshire AL9 7TA, UK., MacRae JI; Metabolomics STP, The Francis Crick Institute, London NW1 1AT, UK., Zelenay S; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Patil KR; MRC Toxicology Unit, University of Cambridge, Cambridge CB2 1QR, UK., Litchfield K; Tumor Immunogenomics and Immunosurveillance (TIGI) Lab, UCL Cancer Institute, London WC1E 6DD, UK., Lee JC; Genetic Mechanisms of Disease Laboratory, The Francis Crick Institute, London NW1 1AT, UK.; Institute of Liver and Digestive Health, Division of Medicine, Royal Free Hospital, University College London, London NW3 2QG, UK., Jess T; National Center of Excellence for Molecular Prediction of Inflammatory Bowel Disease, PREDICT, Faculty of Medicine, Aalborg University, Department of Gastroenterology and Hepatology, Aalborg University Hospital, A DK-2450 Copenhagen, Denmark., Goldszmid RS; Inflammatory Cell Dynamics Section, Laboratory of Integrative Cancer Immunology (LICI), Center for Cancer Research (CCR), National Cancer Institute (NCI), Bethesda, MD 20892, USA., Reis E Sousa C; Immunobiology Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Publikováno v:
Science (New York, N.Y.) [Science] 2024 Apr 26; Vol. 384 (6694), pp. 428-437. Date of Electronic Publication: 2024 Apr 25.
Autor:
Lim KHJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK. Electronic address: jonathan.lim@doctors.org.uk., Westphalen CB; Department of Internal Medicine III, University Hospital LMU Munich, Comprehensive Cancer Centre Munich and German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital Campus, Barcelona, Spain., Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa; Department of Medical Oncology, U.O. Clinical di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Amaral T; Centre for Dermatooncology, Eberhard Karls University of Tübingen, Tübingen; Cluster of Excellence IFIT (EXC2180), Tübingen, Germany.
Publikováno v:
ESMO open [ESMO Open] 2023 Dec; Vol. 8 (6), pp. 102059. Date of Electronic Publication: 2023 Nov 03.
Autor:
Lim KHJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK. Electronic address: jonathan.lim@doctors.org.uk., Westphalen CB; Department of Internal Medicine III, University Hospital LMU Munich, Comprehensive Cancer Centre Munich and German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Berghoff AS; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Cardone C; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy., Connolly EA; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia., Güven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Kfoury M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Kocakavuk E; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany., Mandó P; Clinical Oncology Department, Centro de Educación Médica e Investigaciones Clínicas 'Norberto Quirno' (CEMIC), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina., Mariamidze E; Todua Clinic Department of Oncology and Haematology, Tbilisi, Georgia., Matikas A; Breast Center, Karolinska Comprehensive Cancer Center, Stockholm, Sweden., Moutafi M; Department of Oncology, Attikon University Hospital, Athens, Greece., Oing C; Translational and Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK; Mildred Scheel Cancer Career Centre HaTriCS4, University Cancer Centre Hamburg, University Medical Centre Eppendorf, Hamburg, Germany., Pihlak R; Medical Oncology Department, St Bartholomew's Hospital, London, UK., Punie K; Department of Medical Oncology, GZA Hospitals Sint-Augustinus, Wilrijk, Belgium., Sánchez-Bayona R; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Sobczuk P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Starzer AM; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Tečić Vuger A; Breast Cancer Unit, Medical Oncology Department, University Hospital for Tumors, Sestre Milosrdnice University Hospital Centre, Zagreb, Croatia., Zhu H; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Cruz-Ordinario MVB; Section of Medical Oncology, Cancer Institute, St. Luke's Medical Center, Quezon City, Metro Manila, the Philippines., Altuna SC; Department of Medical Oncology, Oncomédica, Caracas, Venezuela., Canário R; Cancer Metastasis, i3S-Institute for Research & Innovation in Health, Porto; Research Centre, Portuguese Oncology Institute of Porto, Porto; ICBAS, School of Medicine and Biomedical Sciences, Porto, Portugal., Vuylsteke P; Department of Internal Medicine, University of Botswana, Gaborone, Botswana., Banerjee S; Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London; The Institute of Cancer Research, London, UK., de Azambuja E; Institut Jules Bordet and L'Université Libre de Bruxelles (ULB), Brussels, Belgium., Cervantes A; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid; Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria (INCLIVA), Universidad Valencia, Valencia, Spain., Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa; Department of Medical Oncology, U.O. Clinical di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital Campus, Barcelona, Spain., Amaral T; Centre for Dermatooncology, Eberhard Karls University of Tübingen, Tübingen; Cluster of Excellence IFIT (EXC2180), Tübingen, Germany.
Publikováno v:
ESMO open [ESMO Open] 2023 Oct; Vol. 8 (5), pp. 101625. Date of Electronic Publication: 2023 Aug 31.
Autor:
Lim KHJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Ntellas P; Department of Medical Oncology, University Hospital of Ioannina, 45500 Ioannina, Greece., Anderson D; Department of Psycho-Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Simpson L; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Braun M; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Adamou M; School of Human and Health Sciences, Queensgate, University of Huddersfield, Huddersfield HD1 3DH, UK., Barriuso J; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9NT, UK.; Manchester Cancer Research Centre, Manchester M20 0GJ, UK., Dadouli K; Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41222 Larissa, Greece., Connell J; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Williams J; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK.; Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester M13 9PT, UK., Germetaki T; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Lehwald D; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Fitzpatrick N; Department of Psycho-Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Cutting M; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., McCool D; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Hasan J; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Mullamitha S; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Marti K; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Saunders M; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Kamposioras K; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Feb 15; Vol. 15 (4). Date of Electronic Publication: 2023 Feb 15.
Autor:
Lim KHJ; Immunobiology Laboratory, The Francis Crick Institute, London, UK.; Department of Immunology and Inflammation, Imperial College London, London, UK., Giampazolias E; Immunobiology Laboratory, The Francis Crick Institute, London, UK., Schulz O; Immunobiology Laboratory, The Francis Crick Institute, London, UK., Rogers NC; Immunobiology Laboratory, The Francis Crick Institute, London, UK., Wilkins A; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK.; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Sahai E; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., Strid J; Department of Immunology and Inflammation, Imperial College London, London, UK., Reis e Sousa C; Immunobiology Laboratory, The Francis Crick Institute, London, UK caetano@crick.ac.uk.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Sep; Vol. 10 (9).
Autor:
Kamposioras K; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom. Electronic address: konstantinos.kamposioras@nhs.net., Lim KHJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom., Williams J; Department of Pharmacy, The Christie NHS Foundation Trust, Manchester, United Kingdom., Alani M; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Barriuso J; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Collins J; Department of Pharmacy, The Christie NHS Foundation Trust, Manchester, United Kingdom., Marti K; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Braun M; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Mullamitha S; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Hasan J; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Alam N; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Mahmood S; Department of Pharmacy, The Christie NHS Foundation Trust, Manchester, United Kingdom., Finch S; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Bayles L; Department of Pharmacy, The Christie NHS Foundation Trust, Manchester, United Kingdom., King J; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Saunders M; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
Publikováno v:
Clinical colorectal cancer [Clin Colorectal Cancer] 2022 Jun; Vol. 21 (2), pp. e117-e125. Date of Electronic Publication: 2021 Dec 01.
Autor:
Lim KHJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Department of Immunology and Inflammation, Imperial College London, London, UK; Immunobiology Laboratory, The Francis Crick Institute, London, UK., Murali K; Victorian Clinical Genetics Services & Murdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, Australia., Thorne E; Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK., Punie K; Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. Electronic address: https://twitter.com/kevinpunie., Kamposioras K; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Oing C; Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Mildred Scheel Cancer Career Centre HaTriCs4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: https://twitter.com/OingC1., O'Connor M; University Hospital Waterford, Waterford, Ireland., Élez E; Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: https://twitter.com/elena_elez., Amaral T; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany. Electronic address: https://twitter.com/TeresaSAmaral., Garrido P; Medical Oncology, Hospital Ramón y Cajal, IRYCIS, Alcalá University, Madrid, Spain. Electronic address: https://twitter.com/Piuchagarrido., Lambertini M; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genoa, Genoa, Italy. Electronic address: https://twitter.com/matteolambe., Devnani B; Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, Jodhpur, India. Electronic address: https://twitter.com/devnani_bharti., Westphalen CB; Department of Internal Medicine III, University Hospital, LMU Munich and Comprehensive Cancer Center, Munich, Germany. Electronic address: https://twitter.com/BenWestphalen., Morgan G; Department of Medical and Radiation Oncology, Skåne University Hospital, Lund, Sweden. Electronic address: https://twitter.com/weoncologists., Haanen JBAG; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: https://twitter.com/HaanenJohn., Hardy C; Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK., Banerjee S; Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK. Electronic address: susana.banerjee@rmh.nhs.uk.
Publikováno v:
ESMO open [ESMO Open] 2022 Feb; Vol. 7 (1), pp. 100374. Date of Electronic Publication: 2021 Dec 17.
Autor:
Lim KHJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Department of Immunology and Inflammation, Imperial College London, London, UK. Electronic address: jonathan.lim@doctors.org.uk., Solomon BJ; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
Publikováno v:
ESMO open [ESMO Open] 2021 Oct; Vol. 6 (5), pp. 100245. Date of Electronic Publication: 2021 Aug 17.